Characteristic | Survivors (n = 158) | ||
---|---|---|---|
 | Transfused | Not transfused | P |
N (%) | 61 (39) | 97(61) | Â |
Age in months (median, IQR) | 24(14–35) | 31(21–43) | 0.001 |
Proportion < 24 months (%) | 24 | 48 | 0.002 |
Male sex (n, %) | 30(49) | 52(57) | 0.59 |
Admission duration (days) (median, IQR) | 5(4–8) | 4(3–6) | 0.13 |
Review interval (days) (median, IQR) | 28 (25–31) | 28(27–31) | 0.88 |
Respiratory distress (n, %) | 46(76) | 54(56) | 0.001 |
Lactate (mmol/L, mean SD) | 5.8(4.5) | 4.8(3.7) | 0.06 |
Hypoglycaemia (<2.2 mmol/L) (n, %) | 10(16) | 21(22) | 0.239 |
Severe acidosis (Base deficit >15) (n, %) | 37(60) | 45(46) | 0.03 |
Haematological variables | Â | Â | Â |
Admission Hb (mean, SD) | 5.0 (1.9) | 8.3(1.7) | 0.001 |
MCV (mean, SD) | 75.6(6.3) | 74.2(6.8) | 0.09 |
MUAC (mean, SD) | 13.8(1.3) | 14.4(1.5) | 0.02 |
Discharge Hb (mean, SD) | 6.4 (1.5) | 6.8(1.6) | 0.08 |
Follow-up Hb (mean, SD) | 10.2(1.7) | 10.0(1.3) | 0.25 |